(MENAFN- EIN Presswire) EINPresswire / -- King Faisal Specialist Hospital & Research Centre (KFSHRC) advances its patient-safety agenda by pairing rigorous research with deployable clinical technologies that cut risk, improve diagnostic fidelity, and accelerate time-to-treatment across high-acuity pathways. The hospital's model emphasizes translation at speed, ensuring that scientific discovery reaches the bedside in ways that directly improve outcomes and confidence in care.

Within this approach, KFSHRC has operationalized an advanced metagenomic diagnostic protocol for hard-to-detect infections. Using next-generation DNA sequencing, clinicians can identify concealed pathogens and drug-resistant organisms within twenty-four hours, which brings earlier, targeted therapy to the point of care and reduces avoidable delay.

Conventional diagnostics often leave conditions such as meningitis, pneumonia, and sepsis unconfirmed or mischaracterized, which prolongs hospitalization, increases exposure to ineffective treatments, and raises the risk of undetected resistant spread. By delivering a comprehensive genomic signature of infection in a clinically actionable timeframe, KFSHRC's protocol helps teams intervene sooner, align therapy to the organism, and reduce downstream complications for patients and families.

The protocol has already supported more than one hundred complex cases that did not respond to standard regimens. Approximately half of these infections involved antibiotic-resistant microbes, a finding that guided physicians to refine treatment choices, shorten length of stay, and mitigate complication risk. The experience demonstrates how KFSHRC embeds genomics into routine decision-making to strengthen patient safety and elevate the quality of specialized care.

Strategically, this work reflects KFSHRC's vision to integrate precision medicine, infection control, and translational research into a cohesive system that serves both local needs and international benchmarks. It aligns with the hospital's roadmap to scale advanced diagnostics, expand clinician decision-support, and contribute to the Kingdom's broader ambition under Vision 2030 to deliver world-class, innovation-led healthcare that is preventive, efficient, and outcomes-driven.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.

MENAFN17102025003118003196ID1110210218